Results 201 to 210 of about 47,947 (362)
Characteristics of Aerodynamic Five-Hole-Probes in Transonic and Supersonic Flow Regimes
Torsten Fransson, O. Sari
openalex +1 more source
COFs on MOFs: Layer‐by‐Layer Synthesis of MOF@COF Nanoparticles with Synergistic Adsorption
A layer‐by‐layer strategy enables the growth of crystalline covalent organic framework (COF) shells on metal–organic framework nanoparticles, creating core–shell structures with tunable porosity. Ordered interstitial mesopores are formed during shell growth, which are connected with the COF's intrinsic micropores, thereby enhancing water sorption. This
Ana Guillem‐Navajas +11 more
wiley +1 more source
Needle-free vascular access port for hemodialysis: Proof-of-concept validation in an experimental animal study. [PDF]
Canaud B +9 more
europepmc +1 more source
A novel immunotherapeutic strategy combines injectable, adjuvant‐loaded hydrogels with externally controlled histotripsy to create immune‐priming sites within tumors. This approach generates millimeter‐sized immune‐activated lesions with flexible, patient‐tailored treatment scheduling, enabling precise immune activation through tumor ablation‐mediated ...
Sung Hoon Kim +9 more
wiley +1 more source
An approach to flow field prediction over the horizontal axis wind turbine by passive flow control device using CNN-Autoencoder model. [PDF]
Sedighi H +3 more
europepmc +1 more source
Liquid Metal Microrobots for Magnetically Guided Transvascular Navigation
Liquid metal‐based microrobots combine magnetic steering, intrinsic X‐ray visibility and softness, to navigate blood vessels even against flow. Under clinically relevant magnetic fields, liquid metal microrobots roll along vessel walls, cross endothelial barriers, and accumulate in target tissues.
Xiaohui Ju +7 more
wiley +1 more source
Open-access smart blood pump platform for controlling extracorporeal membrane oxygenation. [PDF]
Glomp G +4 more
europepmc +1 more source
ABSTRACT Liver fibrosis is a serious yet reversible intermediate stage in the progression of liver disease, which can ultimately advance to cirrhosis and hepatocellular carcinoma. Targeted and selective inhibition of activated hepatic stellate cells (aHSCs) has emerged as a promising therapeutic strategy for the treatment of liver fibrosis.
Shutong Liu +8 more
wiley +1 more source

